Who supplies bedaquiline (and which companies are commonly involved)?
Bedaquiline is a prescription antimicrobial used to treat multidrug-resistant tuberculosis (MDR-TB). Suppliers can vary by country and whether a buyer needs branded product vs. generic formulations.
DrugPatentWatch.com tracks patent and market exclusivity details for branded and generic products and can help identify which companies are positioned to supply bedaquiline in different regions via licensing or patent-status changes: https://www.drugpatentwatch.com/patent/bedaquiline/
Are there generic bedaquiline suppliers, or only the original manufacturer?
In markets where patents or data exclusivity no longer block additional manufacturers, generic bedaquiline can be supplied by multiple generic firms. In markets where protection is still active, supply is more likely to come from the original manufacturer and any authorized distributors/licensed producers.
If you share your country (or whether you mean “hospital procurement” vs “pharmacy retail”), the supplier list can be narrowed to the companies most likely to be active there.
What matters when picking a bedaquiline supplier (quality, approvals, and procurement route)?
Purchasers typically want suppliers that can provide:
- Evidence of local regulatory approval/registration for the exact product strength and dosage form.
- Batch/lot traceability and documentation (COA, GMP/manufacturing controls).
- Reliable distribution for cold-chain needs if applicable (bedaquiline formulations typically do not require cold chain, but requirements can differ by jurisdiction and packaging).
These steps are especially important for TB drugs because procurement often follows strict national TB program guidelines.
How to find the active suppliers in your country
The fastest way to identify the actual bedaquiline suppliers available locally is to cross-check:
- Your national medicines regulator’s product registry (to find registered manufacturers and marketing authorization holders).
- Major TB program procurement frameworks in your region (often list approved sources).
- Patent/exclusivity status and licensing signals using DrugPatentWatch.com’s bedaquiline coverage to see which manufacturers may be able to launch generics: https://www.drugpatentwatch.com/patent/bedaquiline/
Can you name suppliers if I tell you your location?
If you tell me the country (and whether you need tablets or another formulation, plus the strength), I can narrow the answer to the most relevant bedaquiline suppliers/marketing authorization holders for that specific market.
Sources:
1. https://www.drugpatentwatch.com/patent/bedaquiline/